Helix BioPharma Corp. Reports Voting Results and Appointment of New Board Director - Seite 2

0.1%

Krzysztof Saczek

52,917,442

99.9%

111

0.1%

Adam Uszpolewicz

52,917,442

99.9%

111

0.1%

2. Appointment of Auditor

Marcum LLP was appointed auditor of Helix until the next annual meeting of shareholders at remuneration to be fixed by the directors. Management received proxies in respect of the appointment of the auditor of Helix as follows:

Votes For		Votes Withheld
#	%	#	%
53,429,318	99.9%	111	0.1%

3. Equity Compensation Plan

The resolution approving all unallocated options, rights and other entitlements under Helix's equity compensation plan; ratifying, confirming and approving such plan; and approving the granting by Helix of options, rights and other entitlements under such plan for a further three years until January 28, 2025 were approved by a majority of votes cast by shareholders who voted in respect of the resolution present or represented by proxy at the Meeting. Management received proxies in respect of the foregoing ratification, confirmation and approval with respect to the equity compensation plan as follows: